Intervention Effects of Physical Activity on Type 2 Diabetic Patients Potentially Infected with COVID-19.

The coronavirus disease 2019 (COVID-19) pandemic has clearly had a great influence on the lifestyles of the population, especially on patients with type 2 diabetes mellitus. During the COVID-19 outbreak, many countries/regions implemented social-isolation measures, leading to an increase in negative behaviors and impairing the capability of diabetic patients to resist COVID-19, ultimately causing severe prognoses. Moreover, as the epidemic progressed, multiple studies emphasized the significance of physical exercise in the management of type 2 diabetic patients infected with COVID-19. In this study, we selected research from 1 December 2019 to 9 August 2023 that focused on COVID-19-infected diabetic patients to investigate the impact of type 2 diabetes on the immune functions, inflammation factor levels, lung injuries, and mental disorders of such patients, as well as to assess the risk of novel coronavirus pneumonia in these patients. Additionally, the effects of high-intensity, moderate-intensity, and low-intensity exercises on novel coronavirus pneumonia infection in type 2 diabetic patients and the mechanisms of the effects of such exercise were considered. We concluded that elderly diabetic patients with COVID-19 should perform low-intensity exercises to facilitate their recoveries. This study offers guidance for a proper understanding of the dangers of diabetes and the use of appropriate measures to reduce the risk of novel coronavirus pneumonia infections in type 2 diabetic patients.

The effects of altitude/hypoxic training on oxygen delivery capacity of the blood and aerobic exercise capacity in elite athletes - a meta-analysis.

PURPOSE: This study was designed as a meta-analysis of randomized controlled trials comparing effectiveness of altitude/hypoxic training (experimental) versus sea-level training (control) on oxygen delivery capacity of the blood and aerobic exercise capacity of elite athletes in Korea. METHODS: Databases (Research Information Service System, Korean studies Information Service System, National Assembly Library) were for randomized controlled trials comparing altitude/hypoxic training versus sea-level training in elite athletes. Studies published in Korea up to December 2015 were eligible for inclusion. Oxygen delivery capacity of the blood was quantified by red blood cell (RBC), hemoglobin (Hb), hematocrit (Hct), erythropoietin (EPO); and aerobic exercise capacity was quantified by maximal oxygen consumption (VO2max). RBC, Hb, Hct, VO2max represented heterogeneity and compared post-intervention between altitude/hypoxic training and sea-level training in elite athletes by a random effect model meta-analysis. EPO represented homogeneity and meta-analysis performed by a fixed effect model. Eight independent studies with 156 elite athletes (experimental: n = 82, control: n = 74) were included in the metaanalysis. RESULTS: RBC (4.499×10(5) cell/ul, 95 % CI: 2.469 to 6.529), Hb (5.447 g/dl, 95 % CI: 3.028 to 7.866), Hct (3.639 %, 95 % CI: 1.687 to 5.591), EPO (0.711 mU/mL, 95% CI: 0.282 to 1.140), VO2max (1.637 ml/kg/min, 95% CI: 0.599 to 1.400) showed significantly greater increase following altitude/hypoxic training, as compared with sea-level training. CONCLUSION: For elite athletes in Korea, altitude/ hypoxic training appears more effective than sea-level training for improvement of oxygen delivery capacity of the blood and aerobic exercise capacity.

Association of pro12Ala polymorphism in the peroxisome proliferative-activated receptor gamma2 gene with obesity and hypertension in Korean women.

This study examined whether the Pro12Ala polymorphism of the PPARgamma2 gene is associated with obesity, hypertension and cardiovascular risk profiles in Korean adult women. We studied 129 Korean women (aged 42.71 +/- 8.56 y) who were divided into 2 groups as a Pro12Pro homozygous group and a Pro12Ala heterozygous or Ala12Ala homozygous group based upon PPARy2 genotype. Anthropometric parameters, blood pressure, abdominal fat area and blood lipid profiles were compared between the 2 groups, and the association of Ala allele frequency in PPARgamma2 gene with obesity or hypertension was evaluated. Most anthropometric parameters and blood lipid profiles did not differ significantly between the genotypes. However, all variables of skinfold thickness, body circumference and abdominal fat area of Pro12Ala heterozygous were consistently higher compared to the Pro12Pro homozygous subjects without a significance differences. The hypertensive group had significantly higher (p = 0.004) Ala12 allele frequency than the normotensive group whereas allele frequencies did not differ significantly between the obese group and non-obese group. Ala allele carriers had a significantly higher risk of hypertension than non-carriers in logistic regression analysis. There was no evidence that the Ala allele can be regarded as an independent risk factor for obesity. In conclusion, all variables related to obesity showed a consistently higher trend in Pro12Ala heterozygous subjects compared to Pro12Pro homozygous subjects. Pro12Ala heterozygous subjects showed an increasing trend of elevated blood pressure compared to Pro12Pro homozygous subjects. Ala12 variant as well as BMI and TG were regarded as independent risk factors for hypertension in our subjects.